Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations

NCT07494981 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT07494981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07494981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 25, 2026
Completion date
December 31, 2030
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ceftazidime-avibactam